Oncology Institute grants RSUs to admin chief
England Kristin reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
England Kristin reported acquisition or exercise transactions in this Form 4 filing.
Oncology Institute, Inc. reported that Chief Administrative Officer Kristin England received a grant of 55,743 shares of common stock in the form of restricted stock units (RSUs) at no cash cost. Following this award, she directly holds 153,780 shares of the company’s common stock.
The RSUs vest over four years, with one quarter vesting on the first anniversary of the vesting commencement date and the remaining three quarters vesting in equal annual installments on each of the next three anniversaries, subject to her continued service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 55,743 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates
Key Figures
Key Terms
Restricted Stock Units financial
RSU financial
Vesting Commencement Date financial
continued service financial
FAQ
What insider transaction did TOI report for Kristin England?
What is Kristin England’s total TOI ownership after this Form 4 filing?
How do the RSUs for TOI’s Chief Administrative Officer vest over time?
Is Kristin England’s RSU grant in TOI an open-market stock purchase?
AI-generated analysis. How Rhea-AI works. Not financial advice.